Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence.

Cuccurullo V, Di Stasio GD, Cascini GL, Gatta G, Bianco C.

Diagnostics (Basel). 2019 Sep 24;9(4). pii: E127. doi: 10.3390/diagnostics9040127. Review.

2.

Potential for differentiation of glioma recurrence from radionecrosis using integrated 18F-fluoroethyl-L-tyrosine (FET) positron emission tomography/magnetic resonance imaging: A prospective evaluation.

Sogani SK, Jena A, Taneja S, Gambhir A, Mishra AK, D'Souza MM, Verma SM, Hazari PP, Negi P, Jadhav GK.

Neurol India. 2017 Mar-Apr;65(2):293-301. doi: 10.4103/neuroindia.NI_101_16.

3.

Functional brain imaging: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 1.

4.

Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties?

Romagna A, Unterrainer M, Schmid-Tannwald C, Brendel M, Tonn JC, Nachbichler SB, Muacevic A, Bartenstein P, Kreth FW, Albert NL.

Radiat Oncol. 2016 Oct 21;11(1):139.

5.

The value of 11C-methionine PET in the early differentiation between tumour recurrence and radionecrosis in patients treated for a high-grade glioma and indeterminate MRI.

Garcia JR, Cozar M, Baquero M, Fernández Barrionuevo JM, Jaramillo A, Rubio J, Maida G, Soler M, Riera E.

Rev Esp Med Nucl Imagen Mol. 2017 Mar - Apr;36(2):85-90. doi: 10.1016/j.remn.2016.06.002. Epub 2016 Aug 6. English, Spanish.

PMID:
27503425
6.

More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

PMID:
30843003
7.

Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?

Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S, Ohata K, Goto T, Hara M.

J Neurosurg. 2003 May;98(5):1056-64.

PMID:
12744366
8.

Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.

Okamoto S, Shiga T, Hattori N, Kubo N, Takei T, Katoh N, Sawamura Y, Nishijima K, Kuge Y, Tamaki N.

Ann Nucl Med. 2011 Apr;25(3):213-20. doi: 10.1007/s12149-010-0450-2. Epub 2010 Dec 28.

PMID:
21188660
9.

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.

Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Nishikawa M, Ohata K, Torii K, Morino M, Nishio A, Hara M.

Ann Nucl Med. 2004 Jun;18(4):291-6.

PMID:
15359921
10.

Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.

Jena A, Taneja S, Gambhir A, Mishra AK, Dʼsouza MM, Verma SM, Hazari PP, Negi P, Jhadav GK, Sogani SK.

Clin Nucl Med. 2016 May;41(5):e228-36. doi: 10.1097/RLU.0000000000001152.

PMID:
26859208
11.

Therapeutic strategy of late cerebral radionecrosis. A retrospective study of 21 cases.

Carangelo B, Cerillo A, Mariottini A, Peri G, Rubino G, Mourmouras V, Palma L.

J Neurosurg Sci. 2010 Mar;54(1):21-8.

PMID:
20436395
12.

Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.

Ceccon G, Lohmann P, Stoffels G, Judov N, Filss CP, Rapp M, Bauer E, Hamisch C, Ruge MI, Kocher M, Kuchelmeister K, Sellhaus B, Sabel M, Fink GR, Shah NJ, Langen KJ, Galldiks N.

Neuro Oncol. 2017 Feb 1;19(2):281-288. doi: 10.1093/neuonc/now149.

13.

Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.

Galldiks N, Stoffels G, Filss CP, Piroth MD, Sabel M, Ruge MI, Herzog H, Shah NJ, Fink GR, Coenen HH, Langen KJ.

J Nucl Med. 2012 Sep;53(9):1367-74. doi: 10.2967/jnumed.112.103325. Epub 2012 Aug 7.

14.

Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.

Li H, Deng L, Bai HX, Sun J, Cao Y, Tao Y, States LJ, Farwell MD, Zhang P, Xiao B, Yang L.

AJNR Am J Neuroradiol. 2018 Feb;39(2):280-288. doi: 10.3174/ajnr.A5472. Epub 2017 Dec 14.

15.

[PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree].

Menoux I, Noël G, Namer I, Antoni D.

Cancer Radiother. 2017 Aug;21(5):389-397. doi: 10.1016/j.canrad.2017.03.003. Epub 2017 Jun 7. French.

PMID:
28599998
16.

Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review.

Furuse M, Nonoguchi N, Yamada K, Shiga T, Combes JD, Ikeda N, Kawabata S, Kuroiwa T, Miyatake SI.

Radiat Oncol. 2019 Feb 6;14(1):28. doi: 10.1186/s13014-019-1228-x.

17.

Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [18F]fluoro-borono-phenylalanine PET/CT.

Beshr R, Isohashi K, Watabe T, Naka S, Horitsugi G, Romanov V, Kato H, Miyatake SI, Shimosegawa E, Hatazawa J.

Ann Nucl Med. 2018 Dec;32(10):702-708. doi: 10.1007/s12149-018-1296-2. Epub 2018 Sep 7.

PMID:
30194665
18.

Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.

19.

Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.

Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, Jung HW, Chang KH.

Clin Neurol Neurosurg. 2010 Nov;112(9):758-65. doi: 10.1016/j.clineuro.2010.06.005. Epub 2010 Jul 8.

PMID:
20619531

Supplemental Content

Support Center